These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33626294)

  • 1. Do Circulating Monocytes Promote and Predict Idiopathic Pulmonary Fibrosis Progression?
    Fernandez IE; Kass DJ
    Am J Respir Crit Care Med; 2021 Jul; 204(1):9-11. PubMed ID: 33626294
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood monocyte counts as a potential prognostic marker for idiopathic pulmonary fibrosis: analysis from the Australian IPF registry.
    Teoh AKY; Jo HE; Chambers DC; Symons K; Walters EH; Goh NS; Glaspole I; Cooper W; Reynolds P; Moodley Y; Corte TJ
    Eur Respir J; 2020 Apr; 55(4):. PubMed ID: 31949112
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment on Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults.
    Scholand MB; Wells AU
    Am J Respir Crit Care Med; 2022 Nov; 206(10):1296. PubMed ID: 35868030
    [No Abstract]   [Full Text] [Related]  

  • 4. [How i treat a patient with idiopathic pulmonary fibrosis].
    Guiot J; Duysinx B; Bonhomme O; Louis R; Corhay JL
    Rev Med Liege; 2017 Sep; 72(9):381-383. PubMed ID: 28892311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do all patients with idiopathic pulmonary fibrosis warrant a trial of therapeutic intervention? A pro-con perspective.
    Moodley Y; Corte T; Richeldi L; King TE
    Respirology; 2015 Apr; 20(3):389-94. PubMed ID: 25727967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can monocytes predict prognosis of idiopathic pulmonary fibrosis?
    Kreuter M; Maher TM
    Lancet Respir Med; 2019 Jun; 7(6):467-469. PubMed ID: 30935880
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnosing idiopathic pulmonary fibrosis: Has the time for surgical lung biopsy passed?
    Glenn LM; Corte TJ
    Respirology; 2020 Nov; 25(11):1112-1113. PubMed ID: 32648311
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of progressive lung fibrosis.
    Fioret D; Perez RL; Perez T; Roman J
    Am J Med Sci; 2011 Jun; 341(6):428-30. PubMed ID: 21613928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Idiopathic pulmonary fibrosis].
    Guiot J; Corhay JL; Louis R
    Rev Med Liege; 2014 Nov; 69(11):605-10. PubMed ID: 25796773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic pulmonary fibrosis: guidelines for diagnosis and clinical management have advanced from consensus-based in 2000 to evidence-based in 2011.
    Raghu G
    Eur Respir J; 2011 Apr; 37(4):743-6. PubMed ID: 21454891
    [No Abstract]   [Full Text] [Related]  

  • 11. Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression.
    Yang G; Yang L; Wang W; Wang J; Wang J; Xu Z
    Gene; 2015 May; 562(1):138-44. PubMed ID: 25725128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute exacerbation of idiopathic pulmonary fibrosis: outcome and prognostic factors.
    Simon-Blancal V; Freynet O; Nunes H; Bouvry D; Naggara N; Brillet PY; Denis D; Cohen Y; Vincent F; Valeyre D; Naccache JM
    Respiration; 2012; 83(1):28-35. PubMed ID: 21860222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usual interstitial pneumonia pattern in the diagnosis of idiopathic pulmonary fibrosis?
    Tzilas V; Bouros D
    Lancet Respir Med; 2016 Oct; 4(10):770-772. PubMed ID: 27707457
    [No Abstract]   [Full Text] [Related]  

  • 14. Idiopathic pulmonary fibrosis: lung function is a clinically meaningful endpoint for phase III trials.
    du Bois RM; Nathan SD; Richeldi L; Schwarz MI; Noble PW
    Am J Respir Crit Care Med; 2012 Oct; 186(8):712-5. PubMed ID: 22798316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum biomarkers in idiopathic pulmonary fibrosis.
    van den Blink B; Wijsenbeek MS; Hoogsteden HC
    Pulm Pharmacol Ther; 2010 Dec; 23(6):515-20. PubMed ID: 20708704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for an acute exacerbation of idiopathic pulmonary fibrosis.
    Kakugawa T; Sakamoto N; Sato S; Yura H; Harada T; Nakashima S; Hara A; Oda K; Ishimoto H; Yatera K; Ishimatsu Y; Obase Y; Kohno S; Mukae H
    Respir Res; 2016 Jul; 17(1):79. PubMed ID: 27401332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Exacerbation in Idiopathic Pulmonary Fibrosis].
    Polke M; Kahn N; Kreuter M
    Pneumologie; 2021 Aug; 75(8):601-610. PubMed ID: 34374062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of idiopathic pulmonary fibrosis during immunosuppressive treatment: a case report.
    Cerri S; Sgalla G; Richeldi L; Luppi F
    J Med Case Rep; 2016 May; 10():127. PubMed ID: 27387033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic challenges in Idiopathic Pulmonary Fibrosis: A patient's "Q and A" approach.
    Tzouvelekis A; Tzilas V; Papiris S; Aidinis V; Bouros D
    Pulm Pharmacol Ther; 2017 Feb; 42():21-24. PubMed ID: 27979760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired diversity of the lung microbiome predicts progression of idiopathic pulmonary fibrosis.
    Takahashi Y; Saito A; Chiba H; Kuronuma K; Ikeda K; Kobayashi T; Ariki S; Takahashi M; Sasaki Y; Takahashi H
    Respir Res; 2018 Feb; 19(1):34. PubMed ID: 29486761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.